Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Kilitch Drugs (India)

Sector: Healthcare | Industry: Drugs & Pharma
R 118.10 -4.85  | -3.94% -21.16% 16.16 181.66
NSE Price: Oct 23, 15:44 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 23, 15:44 118.10 -4.85 -3.94% 126.10 122.95 9,682 115.00 - 126.10
BSE Oct 23, 2019 117.70 -5.05 -4.11% 113.10 122.75 740 113.10 - 122.05
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 35,179 P/B: 1.21 NSE Code: KILITCH
52-Week Range: R 92.95 - 242.80 Dividend Yield: 0.42% BSE Code: 524500
TTM EPS: R 7.28 Book Value: R 97.63 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Kilitch Drugs (I) -26.48 -7.03 0.17 -21.53 36.06 33.29 5.07
S&P BSE Small Cap -10.09 -2.52 0.13 -3.04 -0.52 4.40 5.59
S&P BSE Healthcare -7.63 -0.83 0.63 -9.28 -7.66 -1.57 11.31
Company's return has been calculated on basis of BSE's price.
As on Oct 23, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 61.71 57.82 -
Net Profit -25.67 32.80 -
EPS -33.53 31.90 -
Book Value -0.96 -1.23 -
Average
Operating Margin 13.68 10.85 6.07
Net Margin 4.36 -5.33 -12.88
Return on Networth 3.36 -0.09 -2.09
Return on Investment 7.59 1.66 -1.18
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue - -62.86 -
Operating Profit - -88.44 -
Net Profit - -104.90 -
EPS - -104.36 -
TTM
Revenue - - -
Operating Profit - - -
Net Profit - - -
EPS - - -
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Kilitch Drugs (I) 181.66 80.43 11.24 13.33 3.36 1.21 16.16
Astrazeneca Pharma India 6,332.38 771.42 69.56 8.84 20.03 19.78 91.03
Eris Lifesciences 5,764.14 1,005.70 303.64 29.29 28.96 4.67 18.99
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jun 27, 2019 Bhavin Mehta  Buy Inter-Se Transfer 849,116 153.45 1,302.97
Jun 27, 2019 Mukund Mehta  Sell Inter-Se Transfer 849,116 153.45 1,302.97
Aug 31, 2018 Bhavin Mehta  Buy Allotment Of Shares 800,000 137.55 1,100.40
Aug 31, 2018 Mukund Mehta  Buy Allotment Of Shares 173,000 137.55 237.96
Aug 31, 2018 Neeta Mehta  - Allotment Of Shares - 137.55 -
News & Announcements
Contact Information

Company: Kilitch Drugs (India) Ltd.

Address: C 301/2 M I D C, T T C Industrial Area, Pawane Village, Thane, Maharashtra - 400705 | Phone: 022-2767 0322 / 2768 0913 / 6514 4185 | Fax: 022-27680912

Email: [email protected]

Website: www.kilitch.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
7.63
Piotroski F-Score
3
Modified C-Score
2
5-Years Price to Earnings
16.16
5-Years Price to Book
1.21
Earnings Yield
EBIT / Enterprise value
10.09%
PEG
Price / Earnings to growth ratio
0.10
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,531.95 +4.97%
Caplin Point Laboratories R382.95 -1.24%
Eris Lifesciences R421.25 -0.98%
FDC R159.30 -1.03%
JB Chemicals & Pharma R355.00 -1.33%
Laurus Labs R348.00 +1.84%
Strides Pharma Science R343.50 -2.07%
Sun Pharma Adv. Research R129.30 -2.49%
Suven Life Sciences R288.40 +0.61%
Wockhardt R269.80 -1.96%
As on Oct 23, 15:59